Results 31 to 40 of about 2,935 (197)

Aggressive systemic mastocytosis with skin involvement, the type of generaled urticaria pigmentosa (clinical case)

Vestnik Dermatologii i Venerologii, 2017
The authors describe the clinical observation of a case of the aggressive systemic mastocytosis with skin involvement, the type of generalized urticaria pigmentosa.
E. V. Sokolovskiy, V. V. Iastrebov, A. V. Shcherbatykh, E. R. Machulaitene   +3 more
doaj   +1 more source

Neurotensin is increased in serum of young children with autistic disorder [PDF]

, 2010
Autism spectrum disorders (ASD) are a group of pervasive neurodevelopmental disorders diagnosed in early childhood. They are associated with a set of "core symptoms" that include disabilities in social interaction skills, verbal and non-verbal ...
Asimenia Angelidou, Konstantinos Francis, Magdalini Vasiadi, Konstantinos-Dionysios Alysandratos, Bodi Zhang, Athanasios Theoharides, Lefteris Lykouras, Kyriaki Sideri, Dimitrios Kalogeromitros, Theoharis C Theoharides   +9 more
core   +1 more source

Mastocitose sistêmica na infância: relato de 3 casos Systemic mastocytosis in childhood: report of 3 cases

Jornal de Pediatria, 2002
Objetivo: mastocitose é o termo usado para um grupo de moléstias caracterizadas pelo acúmulo de mastócitos na pele, com ou sem comprometimento de outros órgãos.
Evódie I. Fernandes, Beatriz C. de Faria, André Cartell, Boaventura A. dos Santos, Tania F. Cestari   +4 more
doaj   +1 more source

Diagnosis and treatment of urticaria in primary care

İstanbul Kuzey Klinikleri, 2019
Urticaria, also known as hives among people, is a very common disease characterized by erythematous, edematous, itchy, and transient plaques that involve skin and mucous membranes.
Melek Aslan Kayiran, Necmettin Akdeniz
doaj   +1 more source

Prostaglandin D2-supplemented “functional eicosanoid testing and typing” assay with peripheral blood leukocytes as a new tool in the diagnosis of systemic mast cell activation disease: an explorative diagnostic study [PDF]

, 2014
Background: Systemic mast cell activation disease (MCAD) is characterized by an enhanced release of mast cell-derived mediators, including eicosanoids, which induce a broad spectrum of clinical symptoms.
A Böhm, C Akin, Christina Ziemann, D Schäfer, D Schäfer, D Schäfer, D Schäfer, D Schäfer, Dirk Schäfer, E Brzezińska-Błaszczyk, E Torrey, EA Mellor, FW Velten, G Krishnaswamy, G Riccioni, G Woszczek, Gerhard J Molderings, GJ Molderings, GJ Molderings, GJ Molderings, GJ Molderings, GS Katsanos, HJ Cooke, HP Horny, HPM van der Kleij, HW Baenkler, HW Baenkler, I Alvarez-Twose, I Kaneko, J Tolar, JA Awad, JA Boyce, JC Cardet, JD Morrow, JH Butterfield, JH Butterfield, JH Butterfield, JH Butterfield, K Alfter, K Brune, K Karimi, K Karimi, K Nordlind, K Tanaka, K Tatemoto, Katrin Jensen, L Maintz, LJ Roberts, M Frieri, M Kulka, M Raithel, M Reinke, M Schmid, MJ Hamilton, N Sismanopoulos, Norbert-Folke Rath, P Valent, P Valent, Peter Dreßen, PJ Turner, R Ramires, RA Lewis, RC Benyon, S Georgin-Lavialle, S O’Sullivan, SA Krumins, SE Dahlén, SJ Galli, SL Lundström, Stefan Brettner, T Luna-Gomes, T Ugajin, U Abel, U Förster, UW Kolck   +74 more
core   +2 more sources

Chronic Mastocytosis. Case Report and Literature Review

Revista Finlay, 2023
Chronic cutaneous mastocytosis is a genodermatosis of unknown etiology and that is within the group of rare or infrequent diseases. They are characterized by the growth and accumulation of mast cells in the skin and other organs of unknown cause and ...
Iraima Mayón Moya, Danibys Garcell Peña, José Manuel Peraza Ramos   +2 more
doaj  

Insect sting allergy. A study from 1980 to 2003 of patients who started treatment with venom immunotherapy between 1980 and 1998 [PDF]

, 2005
Background Previously we treated patients with insect sting allergy with venom immunotherapy (IT) using whole body insect extracts. From 1980 we changed to insect venoms.
Haye, Rolf, Døsen, Liv K
core   +1 more source

Motives and predictors of modified Atkins diet discontinuation as treatment of adults with drug‐resistant epilepsy

Epilepsia, Volume 67, Issue 1, Page 199-212, January 2026.
Abstract Objective This study was undertaken to explore the motives and predictors of modified Atkins diet (MAD) discontinuation as a treatment of adults with drug‐resistant epilepsy (DRE). Methods A single‐center observational longitudinal study was made of a cohort of patients treated with MAD during the first 6 years at a multidisciplinary ...
Raquel Samões, Ana Cavalheiro, Maria Manuel Tavares, Catarina Teixeira, Bárbara Leal, João Chaves, Sara Cavaco   +6 more
wiley   +1 more source

Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin [PDF]

, 2017
Background. Treatment with omalizumab, a humanized recombinant monoclonal anti-IgE antibody, results in clinical efficacy in patients with Chronic Spontaneous Urticaria (CSU). The mechanism of action of omalizumab in CSU has not been elucidated in detail.
Ashton-Chess, Joanna, Bauer, Andrea, Brehler, Randolf, Canvin, Janice, Erpenbeck, Veit J., Georgiou, Panayiotis, Gericke, Janine, Hillenbrand, Rainer, Jarvis, Philip, Kangas, Michael, Maurer, Marcus, Metz, Martin, Staubach, Petra   +12 more
core   +1 more source

Relapse of Acute Myeloid Leukemia With Concomitant Systemic Mastocytosis Five Years Post Allogenic Hematopoietic Stem Cell Transplantation

Case Reports in Hematology, Volume 2026, Issue 1, 2026.
Systemic mastocytosis (SM) with associated hematological neoplasia (SM‐AHN) is a rare and aggressive condition characterized by abnormal clonal proliferation of mast cells and the concurrent occurrence of hematologic malignancies, such as acute myeloid leukemia (AML).
Sona Vardanyan, Hilde K. Gjelberg, Lars Helgeland, Galina Tsykunova, Rakel Brendsdal Forthun, Håkon Reikvam, Stephen E. Langabeer   +6 more
wiley   +1 more source